Codex DNA to Present at the Cowen 42nd Annual Healthcare Conference

Rhea-AI Summary

SAN DIEGO, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Codex DNA, a leader in automated synthetic biology systems, announces that CEO Todd R. Nelson, PhD, will present virtually at the 42^nd Annual Cowen Healthcare Conference on March 9^th at 2:10 pm ET. He will also participate in a panel on Synthetic Biology Enabling Technologies on March 7^th at 10:30 am ET. Both events will be live-webcasted, with replays available for 30 days post-event. Codex DNA innovates in rapid and accurate DNA/RNA synthesis for various markets, enhancing scientific research worldwide.

SAN DIEGO, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that Todd R. Nelson, PhD, the company’s chief executive officer, will present virtually at the 42^nd Annual Cowen Healthcare Conference on Wednesday, March 9^th at 2:10 pm Eastern time / 11:10 am Pacific Time. Additionally, Todd will participate in a ‘Synthetic Biology Enabling Technologies Panel’ on Monday, March 7^th at 10:30 am Eastern time / 7:30 am Pacific Time.

The presentation and panel discussion will both be webcast live and can be accessed through a link on the investors section of Codex DNA’s website at https://ir.codexdna.com. An archived replay of each webcast will be available for 30 days following the event.

About Codex DNA
Codex DNA is empowering scientists with the ability to create novel, synthetic biology-enabled solutions for many of humanity’s greatest challenges. As inventors of the industry-standard Gibson Assembly® method and the first commercial automated benchtop DNA and mRNA synthesis system, Codex DNA is enabling rapid, accurate, and reproducible writing of DNA and mRNA for numerous downstream markets. The company’s award-winning BioXp™ system consolidates, automates, and optimizes the entire synthesis, cloning, and amplification workflow. As a result, it delivers virtually error-free synthesis of DNA/RNA at scale within days and hours instead of weeks or months. Scientists around the world are using the technology in their own laboratories to accelerate the design-build-test paradigm for novel, high-value products for precision medicine, biologics drug discovery, vaccine and therapeutic development, genome editing, and cell and gene therapy. Codex DNA is a public company based in San Diego. For more information, visit codexdna.com.

Contact:
Richard Lepke
Director of Investor Relations
(619) 840-5392
RichardL@codexdna.com

FAQ

When will Todd R. Nelson present at the Cowen Healthcare Conference for Codex DNA (DNAY)?

Todd R. Nelson will present on March 9^th, 2022, at 2:10 pm ET.

What is the date and time for the Synthetic Biology Enabling Technologies Panel with Codex DNA (DNAY)?

The panel discussion will take place on March 7^th, 2022, at 10:30 am ET.

Where can I watch the live webcasts of Codex DNA (DNAY)'s presentations?

The live webcasts can be accessed through Codex DNA's investor section on their website.

Will there be a replay available for Codex DNA (DNAY)'s conference presentations?

Yes, archived replays will be available for 30 days following each event.

What innovations does Codex DNA (DNAY) focus on in synthetic biology?

Codex DNA specializes in automated DNA and mRNA synthesis, enabling rapid and accurate scientific research.